Suppr超能文献

[地诺前列酮和米索前列醇用于初产妇引产的疗效]

[Efficacy of dinoprostone and misoprostol for labor induction in nulliparous women].

作者信息

Oliveira Tenilson Amaral, Melo Elisa Matias Vieira de, Aquino Márcia Maria Auxiliadora de, Mariani Neto Corintio

机构信息

Serviço de Obstetrícia, Hospital Maternidade Leonor Mendes de Barros, São Paulo, SP, Brasil.

出版信息

Rev Bras Ginecol Obstet. 2011 Mar;33(3):118-22.

Abstract

PURPOSE

to determine the efficacy and safety of dinoprostone and misoprostol for the induction of vaginal childbirth, with or without the use of oxytocin in nulliparous women.

METHODS

in this retrospective observational study, 238 patients were subjected to the induction of delivery from January 2008 to February 2010 with the use of misoprostol 25 mcg by the vaginal route or a pessary containing 10 mg of dinoprostone. A total of 184 patients were selected, with the following characteristics: nulliparous, gestational age of 37-42 weeks, singleton pregnancies, cephalic presentation, intact membranes, and Bishop score < 3. Obstetric and neonatal data were analyzed and compared between groups. The Student t-test, chi-square test and Fisher's exact test were used for statistical analysis, with the level of significance set at p<0.05.

RESULTS

the rate of vaginal childbirth did not differ significantly in patients who used misoprostol and dinoprostone (43.2% versus 50%; p = 0.35, respectively). The ripening of cervix was higher in the group treated with misoprostol (87.3% versus 75.6%, p=0.04). The use of oxytocin was necessary in 58.8% of the misoprostol group and 57.3% in the dinoprostone group after the ripening of cervix. Failed induction was the primary indication of caesarean section delivery in both groups, with no significant difference between them. Fetal and maternal adverse events, such as tachysystole and Apgar scores were similar.

CONCLUSION

dinoprostone and misoprostol are both effective for vaginal childbirth induction, although they need to be combined with oxytocin. They showed a similar safety profile, with misoprostol being more efficient regarding cervical ripening.

摘要

目的

确定地诺前列酮和米索前列醇用于未产妇引产(无论是否使用缩宫素)的有效性和安全性。

方法

在这项回顾性观察研究中,238例患者于2008年1月至2010年2月接受引产,采用阴道途径给予25微克米索前列醇或含10毫克地诺前列酮的阴道栓剂。共选取184例患者,其具有以下特征:未产妇、孕周37 - 42周、单胎妊娠、头先露、胎膜完整且 Bishop 评分<3分。对两组的产科和新生儿数据进行分析和比较。采用 Student t检验、卡方检验和 Fisher 确切检验进行统计分析,显著性水平设定为p<0.05。

结果

使用米索前列醇和地诺前列酮的患者阴道分娩率无显著差异(分别为43.2%和50%;p = 0.35)。米索前列醇治疗组宫颈成熟度更高(87.3%对75.6%,p = 0.04)。宫颈成熟后,米索前列醇组58.8%的患者和地诺前列酮组57.3%的患者需要使用缩宫素。引产失败是两组剖宫产分娩的主要指征,两组之间无显著差异。胎儿和母亲的不良事件,如宫缩过速和阿氏评分相似。

结论

地诺前列酮和米索前列醇在引产方面均有效,尽管它们需要与缩宫素联合使用。它们的安全性相似,米索前列醇在宫颈成熟方面更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验